Literature DB >> 15647039

Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.

N Ghunaim1, H Grönlund, M Kronqvist, R Grönneberg, L Söderström, S Ahlstedt, M van Hage-Hamsten.   

Abstract

BACKGROUND: Most studies on pollen-related food allergy have so far focused on the association of birch/weed pollen allergens and plant food allergy. The aim of this study was to elucidate the allergen spectrum among a group of grass pollen-allergic patients from northern Europe and to relate the results to clinical histories of pollen-related food allergy.
METHODS: Fifty-eight grass pollen-allergic patients answered a questionnaire regarding allergy to foods. Blood samples were taken to test IgE-reactivity to a large panel of pollen allergens and pollen- and nonpollen-related food allergens using crude allergen extracts and recombinant and native allergens.
RESULTS: Three different groups of grass pollen-allergic patients were identified according to their IgE antibody profile: a grass pollen group only (19%), a grass and tree pollen group (29%) and a grass, tree and compositae (pan-) pollen group (48%). No sensitization to Bet v 1 as well as almost no IgE to plant food was observed in the grass pollen group. In contrast, nearly all patients in the two tree-related groups had IgE to Bet v 1, which reflected the high frequency of adverse reactions to typical birch-related food in these groups. Only four patients belonging to the pan-pollen group displayed IgE to profilin Phl p 12/Bet v 2. Patients in the pan-pollen group reported significantly more symptoms to food allergens compared with patients in the two other groups. The most frequently reported symptom was the oral allergy syndrome.
CONCLUSIONS: Sensitization to grass pollen alone is rare among grass pollen-allergic patients from northern Europe. The majority of patients are in addition sensitized to birch (Bet v 1), which seems to be closely related to their pollen-derived food allergy. The study highlights the advantage of using well-defined allergen molecules for the diagnosis of cross-reactivity between pollen and food allergens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647039     DOI: 10.1111/j.1398-9995.2005.00662.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

1.  Panallergens and their impact on the allergic patient.

Authors:  Michael Hauser; Anargyros Roulias; Fátima Ferreira; Matthias Egger
Journal:  Allergy Asthma Clin Immunol       Date:  2010-01-18       Impact factor: 3.406

2.  [Severe type 1-allergy to raw bell pepper].

Authors:  R D Rüger; S Wagner; J C Simon; R Treudler
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

3.  High-density IgE recognition of the major grass pollen allergen Phl p 1 revealed with single-chain IgE antibody fragments obtained by combinatorial cloning.

Authors:  Christoph Madritsch; Elisabeth Gadermaier; Uwe W Roder; Christian Lupinek; Rudolf Valenta; Sabine Flicker
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

4.  Serum IgE profiles in Chinese pollinosis patients with grass pollen sensitisation.

Authors:  Jun-Da Li; Jian-Qing Gu; Ying-Yang Xu; Le Cui; Li-Sha Li; Zi-Xi Wang; Jia Yin; Kai Guan
Journal:  World Allergy Organ J       Date:  2022-01-11       Impact factor: 4.084

5.  Sensitization to timothy grass pollen allergenic molecules in children.

Authors:  Alessandra Scaparrotta; Marcello Verini; Nicola Pietro Consilvio; Anna Cingolani; Daniele Rapino; Marina Attanasi; Marzia Cerasa; Sabrina Di Pillo; Francesco Chiarelli
Journal:  Multidiscip Respir Med       Date:  2013-03-01

6.  Hypersensitivity to major panallergens in a population of 120 patients.

Authors:  Eleonora Nucera; Simona Mezzacappa; Arianna Aruanno; Valentina Pecora; Angela Rizzi; Anna Giulia Ricci; Manuela Ferraironi; Alessandro Buonomo; Domenico Schiavino
Journal:  Postepy Dermatol Alergol       Date:  2015-08-12       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.